855931-72-5

Basic information

• Product Name: 2-(4-bromo-2-ethylphenyl)acetic acid
• Synonyms: 2-(4-bromo-2-ethylphenyl)acetic acid
• CAS NO: 855931-72-5
• Molecular Weight: 243.1
• Mol File: 855931-72-5.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 2-(4-bromo-2-ethylphenyl)acetic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-bromo-2-ethylphenyl)acetic acid(855931-72-5)
• EPA Substance Registry System: 2-(4-bromo-2-ethylphenyl)acetic acid(855931-72-5)

Safety Data

• Hazardous Substances Data: 855931-72-5(Hazardous Substances Data)

Upstream product

• 858817-58-0 (2-ethyl-4-bromo-phenyl)-acetic acid amide 
• 855389-88-7 4-(2-ethyl-4-bromo-phenyl)-pyrrolidine-2,3,5-trione 
• 1037083-14-9 C₁₀H₁₁BrO 
• 877131-21-0 (4-bromo-2-ethylphenyl)methanol 
• 194487-79-1 methyl 4-bromo-2-ethylbenzoate 
• 644984-78-1 4-bromo-2-ethylbenzoic acid 
• 112704-79-7 2-fluoro-4-bromobenzoic acid 

Downstream Products

• 1227090-87-0 methyl 2-(4-bromo-2-ethylphenyl)acetate 

Relevant articles and documents

BENZOFURANE AND BENZOTHIOPHENE DERIVATIVES AS PGE2 RECEPTOR MODULATORS

The present invention relates to benzofurane and benzothiophene derivatives of formula (I) Formula (I) wherein (R1)n, R2, R3, R4a, R4b, R5a, R5b and Ar1 are as described in the description and their use in the treatment of cancer by modulating an immune response comprising a reactivation of the immune system in the tumor. The invention further relates to novel benzofurane and benzothiophene derivatives of formula (II) and their use as pharmaceuticals, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), and especially to their use as modulators of the prostaglandin 2 receptors EP2 and/or EP4.

PHENYL DERIVATIVES AS PGE2 RECEPTOR MODULATORS

The present invention relates to phenyl derivatives of formula (I) Formula (I) wherein (R1)n, R3, R4a, R4b, R5b and Ar1 are as described in the description and their use in the treatment of cancer by modulating an immune response comprising a reactivation of the immune system in the tumor. The invention further relates to novel benzofurane and benzothiophene derivatives of formula (III) and their use as pharmaceuticals, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), and especially to their use as modulators of the prostaglandin 2 receptors EP2 and/or EP4.